[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.74.94. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1997

Familial Juvenile Focal Amyotrophy of the Upper Extremity (Hirayama Disease)Superoxide Dismutase 1 Genotype and Activity

Author Affiliations

From the Department of Neurology (Drs Robberecht, Theys, and Nees), the Laboratory of Neurobiology (Drs Robberecht and Van Den Bosch), and the Center for Human Genetics (Drs Aguirre, Cassiman, and Matthijs), University Hospital Gasthuisberg, Leuven, Belgium.

Arch Neurol. 1997;54(1):46-50. doi:10.1001/archneur.1997.00550130032012
Abstract

Background:  Juvenile focal amyotrophy of the arm is an unusual focal motor neuron disease that is rarely familial. Its pathogenesis is unknown. We recently described a family with amyotrophic lateral sclerosis associated with a mutation in the superoxide dismutase 1 (SOD1) gene substituting an aspartate for an alanine (D9OA). One of the carriers of this mutation had focal and nonprogressive amyotrophy of the arm, suggesting that focal amyotrophy might be associated with SOD1 mutations.

Objectives:  To describe the phenotype of 2 brothers with juvenile focal amyotrophy of the upper extremity and to characterize their SOD1 genotype and SOD activity.

Methods:  Polymerase chain reaction and sequencing of the SOD1 gene and colorimetric measurement of the enzyme activity.

Results:  We compared the phenotype of our patients to that of 375 patients described in the Western literature. The 5 exons of the SOD1 gene were normal, as was the SOD activity in red blood cells.

×